For the Inventor, By the Inventor

Enter inventor name

Véronique Zennou

USPTO Granted Patents = 13

CIPO Patents = 1

EPO Patents = 3 (Patent Applications = 2)

Average Co-Inventor Count = 3.6

ph-index = 6

Forward Citations = 88(Granted Patents)

Location History:

Creteil, FR (2000)
Paris, FR (2011 - 2014)
New York, NY (US) (2016 - 2019)

Company Filing History:

Institut Pasteur

10 out of 5,089

Centre National De La Recherche Scientifique

Institut National De La Sante Et De La Recherche Medicale

Institut National De La Santéde La Recherche Médicale

where one patent can have more than one assignee

Years Active: 2000-2019

Loading Chart...

Loading Chart...

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10407695 - Lentiviral triplex DNA, and vectors and recombinant cells containing lentiviral triplex DNA (2019-09-10),

2. 9238824 - Lentiviral triplex DNA, and vectors and recombinant cells containing lentiviral triplex DNA (2016-01-19),

3. 8652807 - Lentiviral vectors for the preparation of immunotherapeutical compositions (2014-02-18),

4. 8512994 - Lentiviral triplex DNA, and vectors and recombinant cells containing lentiviral triplex DNA (2013-08-20),

5. 8512993 - Lentiviral triplex DNA, and vectors and recombinant cells containing lentiviral triplex DNA (2013-08-20),

6. 8460678 - Use of triplex structure DNA in transferring nucleotide sequences (2013-06-11),

7. 8450087 - Use of triplex structure DNA in transferring nucleotide sequences (2013-05-28),

8. 8367068 - Use of triplex structure DNA in transferring nucleotide sequences (2013-02-05),

9. 8349606 - Lentiviral vectors for the preparation of immunotherapeutical compositions (2013-01-08),

10. 8093042 - Lentiviral triplex DNA, and vectors and recombinant cells containing lentiviral triplex DNA (2012-01-10),

11. 7981671 - Use of triplex structure DNA in transferring nucleotide sequences (2011-07-19),

12. 7968332 - Lentiviral vectors for the preparation of immunotherapeutical compositions (2011-06-28),

13. 6103462 - Rapid single-cycle assay for human immunodeficiency virus type-1 drug (2000-08-15),

I specialize in innovations, inventions, inventors, patent attorneys, assignees, and patents.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…